UniProt ID | PLSL_HUMAN | |
---|---|---|
UniProt AC | P13796 | |
Protein Name | Plastin-2 | |
Gene Name | LCP1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 627 | |
Subcellular Localization |
Cytoplasm, cytoskeleton . Cell junction . Cell projection . Cell projection, ruffle membrane Peripheral membrane protein Cytoplasmic side . Relocalizes to the immunological synapse between peripheral blood T-lymphocytes and antibody-presenting ce |
|
Protein Description | Actin-binding protein. [PubMed: 16636079] | |
Protein Sequence | MARGSVSDEEMMELREAFAKVDTDGNGYISFNELNDLFKAACLPLPGYRVREITENLMATGDLDQDGRISFDEFIKIFHGLKSTDVAKTFRKAINKKEGICAIGGTSEQSSVGTQHSYSEEEKYAFVNWINKALENDPDCRHVIPMNPNTNDLFNAVGDGIVLCKMINLSVPDTIDERTINKKKLTPFTIQENLNLALNSASAIGCHVVNIGAEDLKEGKPYLVLGLLWQVIKIGLFADIELSRNEALIALLREGESLEDLMKLSPEELLLRWANYHLENAGCNKIGNFSTDIKDSKAYYHLLEQVAPKGDEEGVPAVVIDMSGLREKDDIQRAECMLQQAERLGCRQFVTATDVVRGNPKLNLAFIANLFNRYPALHKPENQDIDWGALEGETREERTFRNWMNSLGVNPRVNHLYSDLSDALVIFQLYEKIKVPVDWNRVNKPPYPKLGGNMKKLENCNYAVELGKNQAKFSLVGIGGQDLNEGNRTLTLALIWQLMRRYTLNILEEIGGGQKVNDDIIVNWVNETLREAKKSSSISSFKDPKISTSLPVLDLIDAIQPGSINYDLLKTENLNDDEKLNNAKYAISMARKIGARVYALPEDLVEVNPKMVMTVFACLMGKGMKRV | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MARGSVSDE ------CCCCCCCHH | 25.25 | - | |
5 | Phosphorylation | ---MARGSVSDEEMM ---CCCCCCCHHHHH | 16.94 | 28176443 | |
7 | Phosphorylation | -MARGSVSDEEMMEL -CCCCCCCHHHHHHH | 40.79 | 23401153 | |
11 | Sulfoxidation | GSVSDEEMMELREAF CCCCHHHHHHHHHHH | 2.08 | 21406390 | |
20 | Acetylation | ELREAFAKVDTDGNG HHHHHHHHCCCCCCC | 33.90 | 133035 | |
20 | Ubiquitination | ELREAFAKVDTDGNG HHHHHHHHCCCCCCC | 33.90 | - | |
23 | Phosphorylation | EAFAKVDTDGNGYIS HHHHHCCCCCCCEEE | 49.12 | 28796482 | |
28 | Phosphorylation | VDTDGNGYISFNELN CCCCCCCEEEHHHHH | 9.44 | 27155012 | |
30 | Phosphorylation | TDGNGYISFNELNDL CCCCCEEEHHHHHHH | 17.34 | 28450419 | |
39 | Ubiquitination | NELNDLFKAACLPLP HHHHHHHHHHHCCCC | 42.23 | - | |
41 | Acetylation | LNDLFKAACLPLPGY HHHHHHHHHCCCCCC | 8.93 | - | |
41 | Ubiquitination | LNDLFKAACLPLPGY HHHHHHHHHCCCCCC | 8.93 | - | |
48 | Phosphorylation | ACLPLPGYRVREITE HHCCCCCCCHHHHHH | 12.19 | 23917254 | |
54 | Phosphorylation | GYRVREITENLMATG CCCHHHHHHHHHHCC | 17.67 | - | |
58 | Sulfoxidation | REITENLMATGDLDQ HHHHHHHHHCCCCCC | 4.77 | 21406390 | |
76 | Acetylation | ISFDEFIKIFHGLKS CCHHHHHHHHHCCCC | 44.64 | 19608861 | |
76 | Ubiquitination | ISFDEFIKIFHGLKS CCHHHHHHHHHCCCC | 44.64 | 21906983 | |
82 | Acetylation | IKIFHGLKSTDVAKT HHHHHCCCCHHHHHH | 56.77 | 23749302 | |
82 | Ubiquitination | IKIFHGLKSTDVAKT HHHHHCCCCHHHHHH | 56.77 | 21890473 | |
83 | Phosphorylation | KIFHGLKSTDVAKTF HHHHCCCCHHHHHHH | 34.58 | 30108239 | |
84 | Phosphorylation | IFHGLKSTDVAKTFR HHHCCCCHHHHHHHH | 32.67 | 30108239 | |
88 | Acetylation | LKSTDVAKTFRKAIN CCCHHHHHHHHHHHH | 48.31 | 19608861 | |
88 | Ubiquitination | LKSTDVAKTFRKAIN CCCHHHHHHHHHHHH | 48.31 | 21906983 | |
89 | Phosphorylation | KSTDVAKTFRKAINK CCHHHHHHHHHHHHH | 20.95 | 28122231 | |
97 | Ubiquitination | FRKAINKKEGICAIG HHHHHHHCCCEEEEC | 57.60 | 21890473 | |
106 | O-linked_Glycosylation | GICAIGGTSEQSSVG CEEEECCCCCCCCCC | 24.71 | 32870666 | |
106 | Phosphorylation | GICAIGGTSEQSSVG CEEEECCCCCCCCCC | 24.71 | 30576142 | |
107 | Phosphorylation | ICAIGGTSEQSSVGT EEEECCCCCCCCCCC | 36.59 | 28450419 | |
110 | Phosphorylation | IGGTSEQSSVGTQHS ECCCCCCCCCCCCCC | 23.96 | 28450419 | |
111 | Acetylation | GGTSEQSSVGTQHSY CCCCCCCCCCCCCCC | 25.02 | - | |
111 | Ubiquitination | GGTSEQSSVGTQHSY CCCCCCCCCCCCCCC | 25.02 | - | |
111 | O-linked_Glycosylation | GGTSEQSSVGTQHSY CCCCCCCCCCCCCCC | 25.02 | 32870666 | |
111 | Phosphorylation | GGTSEQSSVGTQHSY CCCCCCCCCCCCCCC | 25.02 | 28450419 | |
114 | Phosphorylation | SEQSSVGTQHSYSEE CCCCCCCCCCCCCHH | 22.43 | 28450419 | |
117 | Phosphorylation | SSVGTQHSYSEEEKY CCCCCCCCCCHHHHH | 22.12 | 23401153 | |
118 | Phosphorylation | SVGTQHSYSEEEKYA CCCCCCCCCHHHHHH | 20.27 | 28450419 | |
119 | O-linked_Glycosylation | VGTQHSYSEEEKYAF CCCCCCCCHHHHHHH | 41.36 | 32870666 | |
119 | Phosphorylation | VGTQHSYSEEEKYAF CCCCCCCCHHHHHHH | 41.36 | 28450419 | |
123 | Ubiquitination | HSYSEEEKYAFVNWI CCCCHHHHHHHHHHH | 45.20 | - | |
124 | Phosphorylation | SYSEEEKYAFVNWIN CCCHHHHHHHHHHHH | 14.46 | 25159151 | |
132 | Ubiquitination | AFVNWINKALENDPD HHHHHHHHHHHCCCC | 45.26 | 21890473 | |
140 | Glutathionylation | ALENDPDCRHVIPMN HHHCCCCCCCCCCCC | 3.84 | 22555962 | |
148 | Acetylation | RHVIPMNPNTNDLFN CCCCCCCCCCHHHHH | 42.65 | - | |
148 | Ubiquitination | RHVIPMNPNTNDLFN CCCCCCCCCCHHHHH | 42.65 | - | |
153 | Ubiquitination | MNPNTNDLFNAVGDG CCCCCHHHHHHHCCC | 3.75 | 21890473 | |
164 | S-palmitoylation | VGDGIVLCKMINLSV HCCCHHEEEECCCCC | 1.62 | 29575903 | |
165 | Ubiquitination | GDGIVLCKMINLSVP CCCHHEEEECCCCCC | 38.36 | 21890473 | |
166 | Sulfoxidation | DGIVLCKMINLSVPD CCHHEEEECCCCCCC | 2.10 | 21406390 | |
170 | Phosphorylation | LCKMINLSVPDTIDE EEEECCCCCCCCCCC | 27.41 | 21712546 | |
179 | Ubiquitination | PDTIDERTINKKKLT CCCCCCCCCCCCCCC | 27.18 | - | |
200 | Phosphorylation | NLNLALNSASAIGCH HHHHHHHHCCCCCCE | 25.17 | 18452278 | |
202 | Phosphorylation | NLALNSASAIGCHVV HHHHHHCCCCCCEEE | 21.90 | 18452278 | |
243 | Phosphorylation | LFADIELSRNEALIA HHCCCEECCCHHHHH | 21.92 | 20068231 | |
257 | Phosphorylation | ALLREGESLEDLMKL HHHHCCCCHHHHHHC | 48.17 | 23401153 | |
262 | Sulfoxidation | GESLEDLMKLSPEEL CCCHHHHHHCCHHHH | 6.76 | 28465586 | |
263 | Acetylation | ESLEDLMKLSPEELL CCHHHHHHCCHHHHH | 53.78 | 26822725 | |
263 | Ubiquitination | ESLEDLMKLSPEELL CCHHHHHHCCHHHHH | 53.78 | - | |
265 | Phosphorylation | LEDLMKLSPEELLLR HHHHHHCCHHHHHHH | 25.42 | 21815630 | |
276 | Phosphorylation | LLLRWANYHLENAGC HHHHHHHHHHHHCCC | 10.47 | 27155012 | |
285 | Ubiquitination | LENAGCNKIGNFSTD HHHCCCCCCCCCCCC | 56.94 | 21890473 | |
290 | Phosphorylation | CNKIGNFSTDIKDSK CCCCCCCCCCCCCCH | 29.21 | 23401153 | |
291 | Phosphorylation | NKIGNFSTDIKDSKA CCCCCCCCCCCCCHH | 37.29 | 22617229 | |
294 | Acetylation | GNFSTDIKDSKAYYH CCCCCCCCCCHHHHH | 59.78 | 19608861 | |
294 | Ubiquitination | GNFSTDIKDSKAYYH CCCCCCCCCCHHHHH | 59.78 | 19608861 | |
296 | Phosphorylation | FSTDIKDSKAYYHLL CCCCCCCCHHHHHHH | 17.74 | 21949786 | |
297 | Acetylation | STDIKDSKAYYHLLE CCCCCCCHHHHHHHH | 51.01 | 19608861 | |
297 | Ubiquitination | STDIKDSKAYYHLLE CCCCCCCHHHHHHHH | 51.01 | 21906983 | |
299 | Phosphorylation | DIKDSKAYYHLLEQV CCCCCHHHHHHHHHH | 8.64 | 28796482 | |
300 | Phosphorylation | IKDSKAYYHLLEQVA CCCCHHHHHHHHHHC | 7.28 | 28796482 | |
322 | Sulfoxidation | VPAVVIDMSGLREKD CCEEEEECCCCCCHH | 2.05 | 21406390 | |
323 | Phosphorylation | PAVVIDMSGLREKDD CEEEEECCCCCCHHH | 30.81 | 30576142 | |
337 | Sulfoxidation | DIQRAECMLQQAERL HHHHHHHHHHHHHHH | 2.59 | 21406390 | |
351 | Phosphorylation | LGCRQFVTATDVVRG HCCCCEEEHHHHHCC | 25.73 | 29978859 | |
353 | Phosphorylation | CRQFVTATDVVRGNP CCCEEEHHHHHCCCC | 21.69 | 28464451 | |
361 | Acetylation | DVVRGNPKLNLAFIA HHHCCCCCCCHHHHH | 54.74 | 19608861 | |
361 | Ubiquitination | DVVRGNPKLNLAFIA HHHCCCCCCCHHHHH | 54.74 | 19608861 | |
374 | Phosphorylation | IANLFNRYPALHKPE HHHHHHHCCCCCCCC | 8.25 | 27155012 | |
379 | Acetylation | NRYPALHKPENQDID HHCCCCCCCCCCCCC | 55.68 | 25953088 | |
379 | Ubiquitination | NRYPALHKPENQDID HHCCCCCCCCCCCCC | 55.68 | - | |
399 | Phosphorylation | GETREERTFRNWMNS CCCHHHHHHHHHHHH | 30.17 | - | |
406 | Phosphorylation | TFRNWMNSLGVNPRV HHHHHHHHCCCCCCH | 15.47 | 23401153 | |
417 | Phosphorylation | NPRVNHLYSDLSDAL CCCHHHHHCCHHHHH | 7.81 | 26356563 | |
418 | Phosphorylation | PRVNHLYSDLSDALV CCHHHHHCCHHHHHH | 38.13 | 26356563 | |
430 | Phosphorylation | ALVIFQLYEKIKVPV HHHHHHHHHHCCCCC | 12.37 | 22817900 | |
432 | Ubiquitination | VIFQLYEKIKVPVDW HHHHHHHHCCCCCCH | 33.98 | - | |
434 | Acetylation | FQLYEKIKVPVDWNR HHHHHHCCCCCCHHH | 52.10 | 25953088 | |
434 | Methylation | FQLYEKIKVPVDWNR HHHHHHCCCCCCHHH | 52.10 | 30783021 | |
434 | Ubiquitination | FQLYEKIKVPVDWNR HHHHHHCCCCCCHHH | 52.10 | - | |
444 | Acetylation | VDWNRVNKPPYPKLG CCHHHCCCCCCCCCC | 44.50 | 26822725 | |
444 | Methylation | VDWNRVNKPPYPKLG CCHHHCCCCCCCCCC | 44.50 | 116252109 | |
444 | Ubiquitination | VDWNRVNKPPYPKLG CCHHHCCCCCCCCCC | 44.50 | - | |
449 | Acetylation | VNKPPYPKLGGNMKK CCCCCCCCCCCCHHH | 54.65 | 25953088 | |
449 | Ubiquitination | VNKPPYPKLGGNMKK CCCCCCCCCCCCHHH | 54.65 | - | |
455 | Acetylation | PKLGGNMKKLENCNY CCCCCCHHHHCCCCC | 59.20 | 25953088 | |
456 | Acetylation | KLGGNMKKLENCNYA CCCCCHHHHCCCCCE | 50.71 | 25953088 | |
456 | Ubiquitination | KLGGNMKKLENCNYA CCCCCHHHHCCCCCE | 50.71 | - | |
468 | Acetylation | NYAVELGKNQAKFSL CCEEEECCCCEEEEE | 59.52 | 25953088 | |
468 | Ubiquitination | NYAVELGKNQAKFSL CCEEEECCCCEEEEE | 59.52 | 19608861 | |
472 | Acetylation | ELGKNQAKFSLVGIG EECCCCEEEEEEEEC | 26.23 | 19608861 | |
472 | Ubiquitination | ELGKNQAKFSLVGIG EECCCCEEEEEEEEC | 26.23 | 19608861 | |
474 | Phosphorylation | GKNQAKFSLVGIGGQ CCCCEEEEEEEECCC | 22.80 | 23401153 | |
502 | Phosphorylation | IWQLMRRYTLNILEE HHHHHHHHHHHHHHH | 12.76 | 21406692 | |
503 | Phosphorylation | WQLMRRYTLNILEEI HHHHHHHHHHHHHHH | 16.12 | 21406692 | |
535 | Phosphorylation | TLREAKKSSSISSFK HHHHHHHHCCCHHCC | 28.72 | 29978859 | |
536 | Phosphorylation | LREAKKSSSISSFKD HHHHHHHCCCHHCCC | 40.34 | 29978859 | |
537 | Phosphorylation | REAKKSSSISSFKDP HHHHHHCCCHHCCCC | 33.31 | 29978859 | |
539 | Phosphorylation | AKKSSSISSFKDPKI HHHHCCCHHCCCCCC | 31.50 | 20068231 | |
540 | Phosphorylation | KKSSSISSFKDPKIS HHHCCCHHCCCCCCC | 34.35 | 29978859 | |
542 | Acetylation | SSSISSFKDPKISTS HCCCHHCCCCCCCCC | 75.07 | 19608861 | |
542 | Ubiquitination | SSSISSFKDPKISTS HCCCHHCCCCCCCCC | 75.07 | 21906983 | |
545 | Ubiquitination | ISSFKDPKISTSLPV CHHCCCCCCCCCCCH | 60.46 | - | |
547 | Phosphorylation | SFKDPKISTSLPVLD HCCCCCCCCCCCHHH | 20.33 | 20068231 | |
548 | O-linked_Glycosylation | FKDPKISTSLPVLDL CCCCCCCCCCCHHHH | 37.44 | 32870666 | |
548 | Phosphorylation | FKDPKISTSLPVLDL CCCCCCCCCCCHHHH | 37.44 | 20068231 | |
549 | O-linked_Glycosylation | KDPKISTSLPVLDLI CCCCCCCCCCHHHHH | 24.72 | 32870666 | |
549 | Phosphorylation | KDPKISTSLPVLDLI CCCCCCCCCCHHHHH | 24.72 | 20068231 | |
563 | Phosphorylation | IDAIQPGSINYDLLK HHHHCCCCCCHHHHC | 17.84 | 20068231 | |
566 | Phosphorylation | IQPGSINYDLLKTEN HCCCCCCHHHHCCCC | 13.29 | 20068231 | |
579 | Acetylation | ENLNDDEKLNNAKYA CCCCCHHHHHHHHHH | 64.61 | 19608861 | |
579 | Ubiquitination | ENLNDDEKLNNAKYA CCCCCHHHHHHHHHH | 64.61 | 19608861 | |
584 | Acetylation | DEKLNNAKYAISMAR HHHHHHHHHHHHHHH | 37.02 | 25953088 | |
584 | Ubiquitination | DEKLNNAKYAISMAR HHHHHHHHHHHHHHH | 37.02 | 21890473 | |
589 | Sulfoxidation | NAKYAISMARKIGAR HHHHHHHHHHHHCCE | 3.23 | 21406390 | |
598 | Nitration | RKIGARVYALPEDLV HHHCCEEEECCHHHH | 9.25 | - | |
598 | Phosphorylation | RKIGARVYALPEDLV HHHCCEEEECCHHHH | 9.25 | 25147952 | |
610 | Ubiquitination | DLVEVNPKMVMTVFA HHHCCCHHHHHHHHH | 38.63 | - | |
614 | Phosphorylation | VNPKMVMTVFACLMG CCHHHHHHHHHHHHC | 10.89 | 22817900 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
5 | S | Phosphorylation | Kinase | PRKACA | P17612 | GPS |
5 | S | Phosphorylation | Kinase | PKCA | P17252 | PSP |
5 | S | Phosphorylation | Kinase | PRKCD | Q05655 | GPS |
5 | S | Phosphorylation | Kinase | RPS6KA1 | Q15418 | GPS |
5 | S | Phosphorylation | Kinase | RPS6KA3 | P51812 | GPS |
5 | S | Phosphorylation | Kinase | PKA-FAMILY | - | GPS |
5 | S | Phosphorylation | Kinase | PKA_GROUP | - | PhosphoELM |
7 | S | Phosphorylation | Kinase | PKA-FAMILY | - | GPS |
7 | S | Phosphorylation | Kinase | PKA_GROUP | - | PhosphoELM |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of PLSL_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of PLSL_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
RD23B_HUMAN | RAD23B | physical | 22939629 | |
CNDP2_HUMAN | CNDP2 | physical | 26344197 | |
PLSI_HUMAN | PLS1 | physical | 28514442 | |
PLST_HUMAN | PLS3 | physical | 28514442 | |
RNF41_HUMAN | RNF41 | physical | 28514442 | |
TTL_HUMAN | TTL | physical | 28514442 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-76; LYS-88; LYS-294;LYS-297; LYS-361; LYS-472; LYS-542 AND LYS-579, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-5; SER-7; TYR-28 ANDSER-30, AND MASS SPECTROMETRY. | |
"Phosphorylation analysis of primary human T lymphocytes usingsequential IMAC and titanium oxide enrichment."; Carrascal M., Ovelleiro D., Casas V., Gay M., Abian J.; J. Proteome Res. 7:5167-5176(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-5, AND MASSSPECTROMETRY. | |
"Costimulation induced phosphorylation of L-plastin facilitatessurface transport of the T cell activation molecules CD69 and CD25."; Wabnitz G.H., Koecher T., Lohneis P., Stober C., Konstandin M.H.,Funk B., Sester U., Wilm M., Klemke M., Samstag Y.; Eur. J. Immunol. 37:649-662(2007). Cited for: SUBCELLULAR LOCATION, FUNCTION, MUTAGENESIS OF SER-5, PHOSPHORYLATIONAT SER-5, AND MASS SPECTROMETRY. | |
"Phosphorylation on Ser5 increases the F-actin-binding activity of L-plastin and promotes its targeting to sites of actin assembly incells."; Janji B., Giganti A., De Corte V., Catillon M., Bruyneel E., Lentz D.,Plastino J., Gettemans J., Friederich E.; J. Cell Sci. 119:1947-1960(2006). Cited for: FUNCTION, ACTIN-BINDING, INTERACTION WITH ACTIN FIBERS, SUBCELLULARLOCATION, MUTAGENESIS OF SER-5, AND PHOSPHORYLATION AT SER-5. | |
"Global survey of phosphotyrosine signaling identifies oncogenickinases in lung cancer."; Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.; Cell 131:1190-1203(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-28 AND TYR-276, AND MASSSPECTROMETRY. | |
"Immunoaffinity profiling of tyrosine phosphorylation in cancercells."; Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,Zha X.-M., Polakiewicz R.D., Comb M.J.; Nat. Biotechnol. 23:94-101(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-124, AND MASSSPECTROMETRY. |